SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
68.16 -0.85  -1.23% NYSE Arca Feb 22, 14:45 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Expense Ratio 0.35%
Share Class Assets Under Management 2.742B
30-Day Average Daily Volume Upgrade
Net Asset Value 68.97
Discount or Premium to NAV 0.06%
Turnover Ratio 75.00

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 9.28% 5.88% 2
3M 4.02% 5.10% 68
6M 11.66% 2.31% 3
1Y 28.75% 14.97% 2
3Y 9.79% 7.43% 6
5Y 21.11% 16.94% 1
As of Feb. 21, 2017
Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 99.92% 99.92% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.08% 0.08% 0.00
As of Feb. 17, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Feb. 17, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Feb. 17, 2017

XBI Stock Market Capitalization

Giant 8.72%
Large 10.95%
Medium 21.26%
Small 41.18%
Micro 17.89%
As of Feb. 17, 2017

XBI Stock Style Exposure

Large Cap Value 0.00
Large Cap Blend 4.60%
Large Cap Growth 15.70%
Mid Cap Value 0.00
Mid Cap Blend 0.00
Mid Cap Growth 21.76%
Small Cap Value 0.15%
Small Cap Blend 6.12%
Small Cap Growth 51.66%
As of Feb. 17, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
CLVS Clovis Oncology Inc 3.71% 62.12 -1.38%
ACAD ACADIA Pharmaceuticals Inc 3.02% 39.17 -0.08%
TSRO Tesaro Inc 3.01% 190.30 +0.02%
EXEL Exelixis Inc 2.82% 22.66 -1.95%
EXAS Exact Sciences Corp 2.65% 23.21 +3.57%
UTHR United Therapeutics Corp 2.62% 149.49 -10.98%
ICPT Intercept Pharmaceuticals Inc 2.49% 123.66 -1.43%
AMGN Amgen Inc 2.48% 172.87 -0.16%
INCY Incyte Corp 2.46% 122.13 -0.19%
KITE Kite Pharma Inc 2.45% 54.23 -1.42%
As of Feb. 17, 2017
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 2.26 yrs
Michael Feehily 5.26 yrs
Raymond Donofrio 0.08 yrs

XBI Net Fund Flows

1M 9.882M
3M -7.898M
6M 452.84M
YTD 9.882M
1Y 708.33M
3Y 1.226B
5Y 1.391B
10Y 1.845B
As of Jan. 31, 2017

XBI Risk Info

Beta (5Y) 1.389
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.7097
Historical Sortino (All) 0.9235
30-Day Rolling Volatility 24.51%
Daily Value at Risk (VaR) 1% (All) 4.92%
Monthly Value at Risk (VaR) 1% (All) 21.48%

XBI Fundamentals

Dividend Yield TTM (2-22-17) 0.22%
SEC Yield (2-17-17) 0.02%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.297
Weighted Average Price to Book Ratio 5.254
Weighted Median ROE -9.43%
Weighted Median ROA -20.74%
Forecasted Dividend Yield 0.16%
Forecasted PE Ratio 21.43
Forecasted Price to Sales Ratio 4.041
Forecasted Price to Book Ratio 4.190
Number of Holdings 88
As of Feb. 17, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 28.08%
Forecasted Book Value Growth 8.84%
Forecasted Cash Flow Growth 18.81%
Forecasted Earnings Growth 31.84%
Forecasted Revenue Growth 20.70%
As of Feb. 17, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.